BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37126322)

  • 1. Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy.
    Khoshkhoo S; Wang Y; Chahine Y; Erson-Omay EZ; Robert SM; Kiziltug E; Damisah EC; Nelson-Williams C; Zhu G; Kong W; Huang AY; Stronge E; Phillips HW; Chhouk BH; Bizzotto S; Chen MH; Adikari TN; Ye Z; Witkowski T; Lai D; Lee N; Lokan J; Scheffer IE; Berkovic SF; Haider S; Hildebrand MS; Yang E; Gunel M; Lifton RP; Richardson RM; Blümcke I; Alexandrescu S; Huttner A; Heinzen EL; Zhu J; Poduri A; DeLanerolle N; Spencer DD; Lee EA; Walsh CA; Kahle KT
    JAMA Neurol; 2023 Jun; 80(6):578-587. PubMed ID: 37126322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis.
    Carton RJ; Doyle MG; Kearney H; Steward CA; Lench NJ; Rogers A; Heinzen EL; McDonald S; Fay J; Lacey A; Beausang A; Cryan J; Brett F; El-Naggar H; Widdess-Walsh P; Costello D; Kilbride R; Doherty CP; Sweeney KJ; O'Brien DF; Henshall DC; Delanty N; Cavalleri GL; Benson KA
    Epilepsia; 2024 May; 65(5):1451-1461. PubMed ID: 38491957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis.
    Furukawa A; Kakita A; Chiba Y; Kitaura H; Fujii Y; Fukuda M; Kameyama S; Shimada A
    Epilepsy Res; 2020 Dec; 168():106502. PubMed ID: 33197783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult focal cortical dysplasia may predict poor outcome of surgery for drug-resistant mesial temporal lobe epilepsy.
    Nowak A; Bala A
    PLoS One; 2021; 16(9):e0257678. PubMed ID: 34591859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma Knife radiosurgery for recurrent or residual seizures after anterior temporal lobectomy in mesial temporal lobe epilepsy patients with hippocampal sclerosis: long-term follow-up results of more than 4 years.
    Lee EM; Kang JK; Kim SJ; Hong SH; Ko TS; Lee SA; Lee DH; Lee JK
    J Neurosurg; 2015 Dec; 123(6):1375-82. PubMed ID: 26162046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
    Mao C; Jin L; Dou W; Lu Q; Zhou L; Ren H; Zhao Y; Feng F; Guo Y; Gao J
    Epilepsy Res; 2019 Nov; 157():106189. PubMed ID: 31472401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal and neocortical BRAF mutant non-expansive lesions in focal epilepsies.
    Lerond J; Mathon B; Scopin M; Nichelli L; Guégan J; Bertholle C; Izac B; Andrieu M; Gareau T; Donneger F; Mohand Oumoussa B; Letourneur F; Tran S; Bertrand M; Le Roux I; Touat M; Dupont S; Poncer JC; Navarro V; Bielle F
    Neuropathol Appl Neurobiol; 2023 Oct; 49(5):e12937. PubMed ID: 37740653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients: in situ microvoltammetric studies.
    Broderick PA; Pacia SV; Doyle WK; Devinsky O
    Brain Res; 2000 Sep; 878(1-2):48-63. PubMed ID: 10996135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus.
    Bencurova P; Baloun J; Musilova K; Radova L; Tichy B; Pail M; Zeman M; Brichtova E; Hermanova M; Pospisilova S; Mraz M; Brazdil M
    Epilepsia; 2017 Oct; 58(10):1782-1793. PubMed ID: 28815576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mTOR pathway is activated in glial cells in mesial temporal sclerosis.
    Sosunov AA; Wu X; McGovern RA; Coughlin DG; Mikell CB; Goodman RR; McKhann GM
    Epilepsia; 2012 Jun; 53 Suppl 1():78-86. PubMed ID: 22612812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM; Velasco TR; Wichert-Ana L; Dos Santos AC; Sakamoto AC
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD4 and CD8 T cells expressing pro-inflammatory cytokines in a cohort of mesial temporal lobe epilepsy patients with hippocampal sclerosis.
    Rosa DV; Rezende VB; Costa BS; Mudado F; Schütze M; Torres KC; Martins LC; Moreira-Filho CA; Miranda DM; Romano-Silva MA
    Epilepsy Res; 2016 Feb; 120():1-6. PubMed ID: 26709876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography.
    Youngerman BE; Oh JY; Anbarasan D; Billakota S; Casadei CH; Corrigan EK; Banks GP; Pack AM; Choi H; Bazil CW; Srinivasan S; Bateman LM; Schevon CA; Feldstein NA; Sheth SA; McKhann GM;
    Epilepsia; 2018 Mar; 59(3):595-606. PubMed ID: 29392715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of excitatory synaptic transmission in the hippocampus and anterior temporal lobe by cyclin dependent kinase 5 (Cdk5) in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS).
    Banerjee J; Srivastava A; Sharma D; Dey S; Tripathi M; Sharma MC; Sarat Chandra P; Banerjee Dixit A
    Neurosci Lett; 2021 Sep; 761():136096. PubMed ID: 34217817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal lobe structural evaluation after transsylvian selective amygdalohippocampectomy.
    Giacomini L; de Souza JPSA; Formentin C; de Campos BM; Todeschini AB; de Oliveira E; Tedeschi H; Joaquim AF; Cendes F; Ghizoni E
    Neurosurg Focus; 2020 Apr; 48(4):E14. PubMed ID: 32234992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early identification of seizure freedom with medical treatment in patients with mesial temporal lobe epilepsy and hippocampal sclerosis.
    Cheval M; Houot M; Chastan N; Szurhaj W; Marchal C; Catenoix H; Valton L; Gavaret M; Herlin B; Biraben A; Lagarde S; Mazzola L; Minotti L; Maillard L; Dupont S
    J Neurol; 2023 May; 270(5):2715-2723. PubMed ID: 36763175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional substrate for memory function differences between patients with left and right mesial temporal lobe epilepsy associated with hippocampal sclerosis.
    Jin SH; Chung CK
    Epilepsy Behav; 2015 Oct; 51():251-8. PubMed ID: 26300534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsive Neurostimulation of the Mesial Temporal White Matter in Bilateral Temporal Lobe Epilepsy.
    Nunna RS; Borghei A; Brahimaj BC; Lynn F; Garibay-Pulido D; Byrne RW; Rossi MA; Sani S
    Neurosurgery; 2021 Jan; 88(2):261-267. PubMed ID: 33026439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesial temporal lobe epilepsy with hippocampal sclerosis is a network disorder with altered cortical hubs.
    Jin SH; Jeong W; Chung CK
    Epilepsia; 2015 May; 56(5):772-9. PubMed ID: 25809843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 18-year follow-up of seizure outcome after surgery for temporal lobe epilepsy and hippocampal sclerosis.
    Hemb M; Palmini A; Paglioli E; Paglioli EB; Costa da Costa J; Azambuja N; Portuguez M; Viuniski V; Booij L; Nunes ML
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):800-5. PubMed ID: 23408065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.